CureVac

Germany’s CureVac CVAC -4.61% NV said it would shelve its most advanced Covid-19 vaccine and focus on a new version, in the latest sign…

German biotech CureVac is abandoning its first coronavirus vaccine candidate to focus on a more promising second-generation jab it is developing with British pharmaceutical company…

The German company CureVac announced Tuesday that it was withdrawing its mRNA vaccine for Covid-19 from the approval process in Europe. The company pulled the plug after determining that it…

An employee of German biopharmaceutical company CureVac, demonstrates research on a vaccine for the coronavirus (COVID-19) disease at a laboratory in Tuebingen, Germany, March 12,…

However, it showed higher efficacy and offered 100-percent protection against hospitalisation and death in people aged 18 to 60 years.…

Shares in Germany’s CureVac CVAC -3.47% NV fell by almost half in premarket trading, pointing to hefty losses for investors when the…

A volunteer receives a dose of CureVac vaccine or a placebo during a study by the German biotech firm CureVac as part of a testing for a new vaccine against the coronavirus disease…